Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest Profit Margin

Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of profit margin. The trailing-twelve-month profit margin at Trinity Biotech plc

is 20.11%. TRIB's revenue for the same period is $79.32 million. The trailing-twelve-month profit margin at Meridian Bioscience Inc

is 17.59%. VIVO's PEG ratio is 1.27. The trailing-twelve-month profit margin at Neogen Corp

is 12.53%. NEOG's operating margin for the same period is 18.75%. The trailing-twelve-month profit margin at Abaxis Inc

is 8.36%. ABAX's ROE for the same period is 7.97%.